Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01696331 · ClinicalTrials.gov registry record · NA
Text Messaging for Adherence in Adolescent Liver Transplant Recipients
A NA study of Liver Transplant and Adherence, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01696331 is a NA study of Liver Transplant and Adherence that has completed, run by Stanford University. The registered enrollment target is 42 participants, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01696331, a NA study of Liver Transplant and Adherence, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.
Conditions Studied
Interventions
- BEHAVIORAL Text Message Reminder
Study Locations (1)
California
- Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2012-09 |
| Est. Completion | 2013-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01696331
The ClinicalTrials.gov registry entry for NCT01696331 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which Text Message Reminder is the first listed.
NCT01696331 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01696331 about?
NCT01696331 is a clinical study titled "Text Messaging for Adherence in Adolescent Liver Transplant Recipients". Text message reminders will improve adherence to lab tests in adolescent liver transplant recipients.
What is the current status of trial NCT01696331?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2012-09. Estimated completion is 2013-01.
What conditions does trial NCT01696331 study?
This clinical trial studies the following conditions: Liver Transplant, Adherence.
What interventions are being tested in trial NCT01696331?
The interventions under investigation include: Text Message Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT01696331?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01696331 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Auriculo-Nerve Stimulation on Post-Operative Opioid Requirement
RECRUITING · NA
-
Normothermic Machine Perfusion of Steatotic Livers for Expansion of Donor Organ Pool
RECRUITING · NA
-
OCS Liver PROTECT Continued Access Protocol
COMPLETED · NA
-
Increasing Activity in Liver Transplant Patients
COMPLETED · NA
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.